Manufacturer of Controlled Substances; Notice of Registration, 48980 [05-16566]

Download as PDF 48980 Federal Register / Vol. 70, No. 161 / Monday, August 22, 2005 / Notices made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II: DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 25, 2004, Navinta LLC, 1499 Lower Ferry Road, Ewing, New Jersey 08616–1414, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic class of controlled substances listed in Schedule II: Drug a bulk manufacturer of the basic class of controlled substances listed in Schedule II. Drug Cocaine (9041) ......................... Benzoylecgonine (9180) ........... Schedule Lysergic Acid Diethylamide (7315) .................................... Tetrahydrocannabinol (7370) ... Alphamethadol (9605) .............. Phencyclidine (7471) ................ Benzoylecgonine (9180) ........... Methadone (9250) .................... Morphine (9300) ....................... I I I II II II II The company plans to manufacture small quantities of the listed controlled Fentanyl (9801) ........................ II substances for use in diagnostic Sufentanil (9740) ...................... II products. No comments or objections have been received. DEA has considered the The company plans to bulk factors in 21 U.S.C. 823(a) and manufacture the controlled substances for product development of generic and determined that the registration of Roche Diagnostics Operations Inc. to brand pharmaceutical products. Any other such applicant and any manufacture the listed basic classes of person who is presently registered with controlled substances is consistent with DEA to manufacture such a substance the public interest at this time. DEA has may file comments or objections to the investigated Roche Diagnostics issuance of the proposed registration Operations Inc. to ensure that the pursuant to 21 CFR 1301.33(a). company’s registration is consistent Any such written comments or with the public interest. The objections being sent via regular mail investigation has included inspection may be addressed, in quintuplicate, to and testing of the company’s physical the Deputy Assistant Administrator, security systems, verification of the Office of Diversion Control, Drug company’s compliance with state and Enforcement Administration, local laws, and a review of the Washington, DC 20537, Attention: DEA company’s background and history. Federal Register Representative, Liaison Therefore, pursuant to 21 U.S.C. 823, and Policy Section (ODL); or any being and in accordance with 21 CFR 1301.33, sent via express mail should be sent to the above named company is granted DEA Headquarters, Attention: DEA registration as a bulk manufacturer of Federal Register Representative/ODL, the basic classes of controlled 2401 Jefferson-Davis Highway, substances listed. Alexandria, Virginia 22301; and must be Dated: August 15, 2005. filed no later than October 21, 2005. Drug Schedule Dated: August 15, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–16567 Filed 8–19–05; 8:45 am] William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–16568 Filed 8–19–05; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration Manufacturer of Controlled Substances; Notice of Registration By notice dated April 25, 2005, and published in the Federal Register on May 2, 2005, (70 FR 22704), Roche Diagnostics Operations Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis, Indiana 46250, VerDate jul<14>2003 16:09 Aug 19, 2005 Jkt 205001 By notice dated March 29, 2005, and published in the Federal Register on April 5 2005 (70 FR 17263), Stepan Company, Natural Products Dept., 100 W. Hunter Avenue, Maywood, New Jersey 07607, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Schedule II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Stepan Company to manufacture the listed basic class of controlled substances is consistent with the public interest at this time. DEA has investigated Stepan Company to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substances listed. Dated: August 15, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–16566 Filed 8–19–05; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By notice dated March 29, 2005, and published in the Federal Register on April 6, 2005, (70 FR 17474–17475), Varian, Inc., Lake Forest, 25200 Commercentre Drive, Lake Forest, California 92630–8810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic class of controlled substances listed in Schedule II: Drug Phencyclidine (7471) ................ 1-Piperidinocyclohexanecarbonitrile (8603) ................. Benzoylecgonine (9180) ........... E:\FR\FM\22AUN1.SGM 22AUN1 Schedule II II II

Agencies

[Federal Register Volume 70, Number 161 (Monday, August 22, 2005)]
[Notices]
[Page 48980]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16566]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By notice dated March 29, 2005, and published in the Federal 
Register on April 5 2005 (70 FR 17263), Stepan Company, Natural 
Products Dept., 100 W. Hunter Avenue, Maywood, New Jersey 07607, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic class of controlled 
substances listed in Schedule II.

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
Cocaine (9041).............................................           II
Benzoylecgonine (9180).....................................           II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Stepan Company to manufacture the listed basic class of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Stepan Company to ensure that the company's registration 
is consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic class of controlled substances listed.

    Dated: August 15, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-16566 Filed 8-19-05; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.